Health AI Central
Share:
Peer-Reviewed Publication
J Urol2024;212(1):52-62.July 1, 2024Journal Article

Artificial Intelligence Improves the Ability of Physicians to Identify Prostate Cancer Extent.

Sakina Mohammed Mota1, Alan Priester1,2, Joshua Shubert1, Jeremy Bong1, James Sayre3, Brittany Berry-Pusey1, Wayne G Brisbane2, Shyam Natarajan1,2
1Avenda Health, Inc.
2Department of Urology, David Geffen School of Medicine, Los Angeles, California.
3Department of Radiological Sciences and Biostatistics, University of California, Los Angeles, California.
PubMed PMC DOI PDF

Abstract

PURPOSE: Defining prostate cancer contours is a complex task, undermining the efficacy of interventions such as focal therapy. A multireader multicase study compared physicians' performance using artificial intelligence (AI) vs standard-of-care methods for tumor delineation. MATERIALS AND METHODS: Cases were interpreted by 7 urologists and 3 radiologists from 5 institutions with 2 to 23 years of…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.